IGF1 and cancer: Additional markers such as insulin-like growth factor 1 (IGF-1), vitamin D, and muscle-derived cytokines and myokines have been investigated as potential indicators of muscle mass and function in patients with cancer, but their roles in NET-specific settings are not yet firmly established and are primarily used in research rather than routine care [52,53].